- Home
- KYMR vs KFY Comparison
KYMR vs KFY Comparison
Compare KYMR & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- KFY
- Stock Information
- Founded
- KYMR 2015
- KFY 1969
- Country
- KYMR United States
- KFY United States
- Employees
- KYMR N/A
- KFY N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- KFY Diversified Commercial Services
- Sector
- KYMR Health Care
- KFY Consumer Discretionary
- Exchange
- KYMR Nasdaq
- KFY Nasdaq
- Market Cap
- KYMR 4.2B
- KFY 3.6B
- IPO Year
- KYMR 2020
- KFY 1999
- Fundamental
- Price
- KYMR $56.83
- KFY $70.62
- Analyst Decision
- KYMR Strong Buy
- KFY Buy
- Analyst Count
- KYMR 17
- KFY 2
- Target Price
- KYMR $61.65
- KFY $80.00
- AVG Volume (30 Days)
- KYMR 910.5K
- KFY 470.9K
- Earning Date
- KYMR 10-30-2025
- KFY 09-09-2025
- Dividend Yield
- KYMR N/A
- KFY 2.71%
- EPS Growth
- KYMR N/A
- KFY 33.45
- EPS
- KYMR N/A
- KFY 4.69
- Revenue
- KYMR $44,711,000.00
- KFY $2,763,755,000.00
- Revenue This Year
- KYMR $62.11
- KFY $4.39
- Revenue Next Year
- KYMR N/A
- KFY $4.42
- P/E Ratio
- KYMR N/A
- KFY $15.11
- Revenue Growth
- KYMR N/A
- KFY 0.93
- 52 Week Low
- KYMR $19.45
- KFY $59.23
- 52 Week High
- KYMR $59.00
- KFY $80.64
- Technical
- Relative Strength Index (RSI)
- KYMR 65.68
- KFY 44.36
- Support Level
- KYMR $54.09
- KFY $68.65
- Resistance Level
- KYMR $59.00
- KFY $73.25
- Average True Range (ATR)
- KYMR 2.39
- KFY 1.29
- MACD
- KYMR 0.30
- KFY -0.10
- Stochastic Oscillator
- KYMR 80.00
- KFY 33.81
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About KFY Korn Ferry
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.